MedInvest Semi-Annual MedTech, AI, and Digital Health Conference Announced For October 3-4
MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host its semi-annual Medical Device, AI, and Digital Health Conference October 3-4, 2023 in Mountain View, California. The National Institutes of Health and Fenwick Law Firm will be presenting sponsors of the event.
The conference is expected to attract 125+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.
During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.
Dr. Michael Synder, Stanford W. Ascherman Professor of Genetics at Stanford
Priya Abani, CEO, Alivecor KardiaMobile
Steven Ferguson, Deputy Director, Licensing and Entrepreneurship,
National Institutes of Health
Tamir Meiri, Director, Venture Investments, J&J Innovation
Paul LaViolette,General Partner, SV Health | Former COO and President
International, Boston Scientific
Gowri Raman, Director, Venture Capital at Medtronic
Kevin Chu, Principal, F-Prime Capital
Brian Butler, Partner, Questa Capital
Melody Po, Partner, DigitalDx Ventures
Anne DeGheest, Managing Director, HealthTech Capital
Amit Garg, Partner, Tau Ventures